CBD shows promise in helping smokers quit – new trial underway
NCT ID NCT06218056
First seen Apr 22, 2026 · Last updated Jun 20, 2026 · Updated 13 times
Summary
This study tests whether cannabidiol (CBD) can reduce cigarette smoking in people with tobacco use disorder. Researchers will give 120 participants either CBD or a placebo twice daily for 56 days, measuring nicotine levels and smoking abstinence. The goal is to find a new way to help people quit smoking when current treatments fail.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOBACCO DEPENDENCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CRI-Help, Inc.
RECRUITINGNorth Hollywood, California, 91601, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cannabidiol (CBD)
What this could lead to
If it works, this could offer a new option to help people cut down or quit smoking, especially those who haven't succeeded with existing treatments.
What could go wrong
This is a mid-stage trial with only 120 participants, so results may not apply to everyone. CBD's effectiveness for smoking reduction is not yet proven, and side effects are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.